Active, Not Recruiting
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
NCT02921022
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Cardiovascular Diseases, Digestive System Diseases, +11 more
- Locations
-
- Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
- Miami Cancer Institute Miami, Florida, United States
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States